In the first months of 2026, MIDI Medical Product Development participated in a series of leading MedTech and Biotech conferences spanning advanced therapies, orthopedics, robotics, diagnostics, and digital health.

These forums are where the future of medical technology is actively shaped through collaboration, insight sharing, and real-world problem solving. As technologies continue to converge across hardware, software, and data, these discussions are increasingly focused on managing complexity, risk, and long-term system performance. MIDI’s involvement reflects a commitment to staying informed, contributing perspective, and remaining aligned with the evolving demands of modern device development.

Engagement Across the MedTech & Biotech Ecosystem:

MIDI participated in several key events:

• Advanced Therapies Week – Focused on cell and gene therapies and the growing complexity of integrating biologics with device platforms.
• AAOS Annual Meeting – The leading orthopedic conference showcasing advancements in implants, surgical techniques, and robotics.
• Pittcon – A global event centered on analytical instrumentation and laboratory science critical to diagnostics and validation.
• LSI USA – A premier MedTech investment and partnering forum connecting innovators, strategics, and investors.
• AORN Global Surgical Conference – Dedicated to perioperative and surgical innovation, with emphasis on safety and clinical outcomes.
• Stryker Orthopedic Robotic Innovation Center Summit – Focused on the advancement of robotic-assisted surgery and system integration.
• eMerge Americas (Miami) – A technology-driven event bridging digital health, AI, and broader innovation ecosystems.

Engaging across these forums provides a direct view into how challenges evolve from early innovation through commercialization.

This exposure strengthens MIDI’s ability to support clients by providing insight into emerging regulatory expectations, system integration challenges, and the realities of developing increasingly complex, connected technologies. MIDI’s role extends beyond participation, contributing perspective grounded in real-world product development, particularly around system architecture, regulatory alignment, and scalability.

These events create a continuous exchange of insight between innovators, clinicians, engineers, and investors, reinforcing a shared understanding of where MedTech development is heading. That exchange strengthens MIDI’s ability to deliver informed, practical development solutions to its partners.

Looking Ahead:

MIDI remains committed to active participation in these forums, supporting the advancement of the industry while continuously refining how we help bring safe, effective, and commercially viable medical technologies to market.